This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.Need a new registration confirmation email? Click here

Good day ladies and gentlemen and welcome to the Second Quarter 2012 Avanir Pharmaceuticals Earnings Conference Call. My name is Pam and I will be your operator for today. At this time all participants are in listen-only mode, later we will conduct a question-and-answer session. (Operator Instructions) As a reminder this conference is being recorded for replay purposes.

I’d now like to turn the conference over to Mr. Ian Clements, Senior Director of Investor Relations. Please proceed.

Ian Clements

Thanks Pam. Good morning everybody. I’d like to welcome you to our conference call to discuss our financial and operating results for the fiscal 2012 second quarter.

To discuss our results I’m joined by Keith Katkin, our President and Chief Executive Officer, who will provide a strategic overview of our business and fiscal 2012 second quarter performance; Christine Ocampo, our Vice President of Finance who will provide additional details on our financial performance during the quarter; Rohan Palekar, our Chief Commercial Officer; and Joao Siffert, Senior Vice President, Research and Development, who will provide an R&D update. For the Q&A portion of today’s call we will also be joined by Dr. Randall Kaye, our Chief Medical Officer.